PMC:7200337 / 71348-71574
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T645 | 63-73 | Body_part | denotes | pyrimidine | http://purl.org/sig/ont/fma/fma82773 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T426 | 105-113 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T817 | 37-38 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T67115 | 12-21 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T95482 | 63-73 | Chemical | denotes | pyrimidine | http://purl.obolibrary.org/obo/CHEBI_16898 |
T127 | 159-169 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T52801 | 173-184 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T178 | 74-83 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T179 | 116-122 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2260 | 30-35 | Gene | denotes | DHODH | Gene:1723 |
2264 | 94-96 | Gene | denotes | to | Gene:6999 |
2269 | 105-115 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
2280 | 63-73 | Chemical | denotes | pyrimidine | MESH:C030986 |
2281 | 159-169 | Chemical | denotes | remdesivir | MESH:C000606551 |
2282 | 173-184 | Chemical | denotes | chloroquine | MESH:D002738 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T399 | 0-226 | Sentence | denotes | Further, an inhibitor of host DHODH, a rate-limiting enzyme in pyrimidine synthesis, was able to inhibit SARS-CoV-2 growth in vitro with greater efficacy than remdesivir or chloroquine (Wang et al., 2020e, Xiong et al., 2020). |